TSLP and Alzheimer disease: Similarly, TSLP and CD86 [38], which are indicators of inflammatory diseases, including in AD models, were decreased in a concentration-dependent manner by cASC-EVs, confirming that cASC-EVs exhibit anti-inflammatory effects.